본문 바로가기
KERD
논문KCI 등재

Promising Neuroimaging Biomarkers in Depression

2

조회

0

다운로드

3

인용

0

참고문헌

키워드

주제분류정신과학

초록

The neuroimaging has been applied in the study of pathophysiology in major depressive disorder (MDD). In this review article, several kinds of methodologies of neuroimaging would be discussed to summarize the promising biomarkers in MDD. For the magnetic resonance imaging (MRI) and magnetoencephalography field, the literature review showed the potentially promising roles of frontal lobes, such as anterior cingulate cortex (ACC), dorsolateral prefrontal cortex (DLPFC) and orbitofrontal cortex (OFC). In addition, the limbic regions, such as hippocampus and amygdala, might be the potentially promising biomarkers for MDD. The structures and functions of ACC, DLPFC, OFC, amygdala and hippocampus might be confirmed as the biomarkers for the prediction of antidepressant treatment responses and for the pathophysiology of MDD. The functions of cognitive control and emotion regulation of these regions might be crucial for the establishment of biomarkers. The near-infrared spectroscopy studies demonstrated that blood flow in the frontal lobe, such as the DLPFC and OFC, might be the biomarkers for the field of near-infrared spectroscopy. The electroencephalography also supported the promising role of frontal regions, such as the ACC, DLPFC and OFC in the biomarker exploration, especially for the sleep electroencephalogram to detect biomarkers in MDD. The positron emission tomography (PET) and single-photon emission computed tomography (SPECT) in MDD demonstrated the promising biomarkers for the frontal and limbic regions, such as ACC, DLPFC and amygdala. However, additional findings in brainstem and midbrain were also found in PET and SPECT. The promising neuroimaging biomarkers of MDD seemed focused in the fronto-limbic regions.

Abstract

The neuroimaging has been applied in the study of pathophysiology in major depressive disorder (MDD). In this review article, several kinds of methodologies of neuroimaging would be discussed to summarize the promising biomarkers in MDD. For the magnetic resonance imaging (MRI) and magnetoencephalography field, the literature review showed the potentially promising roles of frontal lobes, such as anterior cingulate cortex (ACC), dorsolateral prefrontal cortex (DLPFC) and orbitofrontal cortex (OFC). In addition, the limbic regions, such as hippocampus and amygdala, might be the potentially promising biomarkers for MDD. The structures and functions of ACC, DLPFC, OFC, amygdala and hippocampus might be confirmed as the biomarkers for the prediction of antidepressant treatment responses and for the pathophysiology of MDD. The functions of cognitive control and emotion regulation of these regions might be crucial for the establishment of biomarkers. The near-infrared spectroscopy studies demonstrated that blood flow in the frontal lobe, such as the DLPFC and OFC, might be the biomarkers for the field of near-infrared spectroscopy. The electroencephalography also supported the promising role of frontal regions, such as the ACC, DLPFC and OFC in the biomarker exploration, especially for the sleep electroencephalogram to detect biomarkers in MDD. The positron emission tomography (PET) and single-photon emission computed tomography (SPECT) in MDD demonstrated the promising biomarkers for the frontal and limbic regions, such as ACC, DLPFC and amygdala. However, additional findings in brainstem and midbrain were also found in PET and SPECT. The promising neuroimaging biomarkers of MDD seemed focused in the fronto-limbic regions.

참고문헌 (124)

  1. Lai CH, "Major depressive disorder : gender differences in symptoms, life quality, and sexual function", J Clin Psychopharmacol, 31, pp.39~44 (2011)
  2. Testa MA, "Assesment of quality-of-life outcomes", N Engl J Med, 334, pp.835~840 (1996)
  3. Naranjo CA, "The role of the brain reward system in depression", Prog Neuropsychopharmacol Biol Psychiatry, 25, pp.781~823 (2001)
  4. Alexopoulos GS, "Functional connectivity in the cognitive control network and the default mode network in late-life depression", J Affect Disord, 139, pp.56~65 (2012)
  5. van Tol MJ, "Regional brain volume in depression and anxiety disorders", Arch Gen Psychiatry, 67, pp.1002~1011 (2010)
  6. Lai CH, "First episode drug-naive major depressive disorder with panic disorder : gray matter deficits in limbic and default network structures", Eur Neuropsychopharmacol, 20, pp.676~682 (2010)
  7. de Kwaasteniet B, "Relation between structural and functional connectivity in major depressive disorder", Biol Psychiatry, 74, pp.40~47 (2013)
  8. Sheline YI, "3D MRI studies of neuroanatomic changes in unipolar major depression : the role of stress and medical comorbidity", Biol Psychiatry, 48, pp.791~800 (2000)
  9. Sheline YI, "The default mode network and self-referential processes in depression", Proc Natl Acad Sci U S A, 106, pp.1942~1947 (2009)
  10. Allman JM, "The anterior cingulate cortex. The evolution of an interface between emotion and cognition", Ann N Y Acad Sci, 935, pp.107~117 (2001)
  11. Bush G, "Cognitive and emotional influences in anterior cingulate cortex", Trends Cogn Sci, 4, pp.215~222 (2000)
  12. Rushworth MF, "Contrasting roles for cingulate and orbitofrontal cortex in decisions and social behaviour", Trends Cogn Sci, 11, pp.168~176 (2007)
  13. Yucel M, "Anterior cingulate dysfunction: implications for psychiatric disorders?", J Psychiatry Neurosci, 28, pp.350~354 (2003)
  14. Devinsky O, "Contributions of anterior cingulate cortex to behaviour", Brain, 118(Pt 1), pp.279~306 (1995)
  15. Mayberg HS, "Limbic-cortical dysregulation : a proposed model of depression", J Neuropsychiatry Clin Neurosci, 9, pp.471~481 (1997)
  16. Ressler KJ, "Targeting abnormal neural circuits in mood and anxiety disorders : from the laboratory to the clinic", Nat Neurosci, 10, pp.1116~1124 (2007)
  17. Bae JN, "Dorsolateral prefrontal cortex and anterior cingulate cortex white matter alterations in late-life depression", Biol Psychiatry, 60, pp.1356~1363 (2006)
  18. Frodl TS, "Depression-related variation in brain morphology over 3 years: effects of stress?", Arch Gen Psychiatry, 65, pp.1156~1165 (2008)
  19. Li CT, "Structural and cognitive deficits in remitting and non-remitting recurrent depression : a voxel-based morphometric study", Neuroimage, 50, pp.347~356 (2010)
  20. Liao C, "Dysfunction of frontolimbic brain circuitry in depression", Neuroscience, 201, pp.231~238 (2012)
  21. Egger K, "Pattern of brain atrophy in elderly patients with depression revealed by voxel-based morphometry", Psychiatry Res, 164, pp.237~244 (2008)
  22. Gatt JM, "Interactions between BDNF Val66Met polymorphism and early life stress predict brain and arousal pathways to syndromal depression and anxiety", Mol Psychiatry, 14, pp.681~695 (2009)
  23. van Eijndhoven P, "Amygdala responsivity related to memory of emotionally neutral stimuli constitutes a trait factor for depression", Neuroimage, 54, pp.1677~1684 (2011)
  24. van Tol MJ, "Functional magnetic resonance imaging correlates of emotional word encoding and recognition in depression and anxiety disorders", Biol Psychiatry, 71, pp.593~602 (2012)
  25. Herringa RJ, "Childhood maltreatment is associated with altered fear circuitry and increased internalizing symptoms by late adolescence", Proc Natl Acad Sci U S A, 110, pp.19119~19124 (2013)
  26. Gabbay V, "The kynurenine pathway in adolescent depression : preliminary findings from a proton MR spectroscopy study", Prog Neuropsychopharmacol Biol Psychiatry, 34, pp.37~44 (2010)
  27. Hahn T, "Integrating neurobiological markers of depression", Arch Gen Psychiatry, 68, pp.361~368 (2011)
  28. Lai CH, "Patterns of cortico-limbic activations during visual processing of sad faces in depression patients : a coordinate-based metaanalysis", J Neuropsychiatry Clin Neurosci, 26, pp.34~43 (2014)
  29. Barch DM, "Functional brain activation to emotionally valenced faces in school-aged children with a history of preschool-onset major depression", Biol Psychiatry, 72, pp.1035~1042 (2012)
  30. Gaffrey MS, "Disrupted amygdala reactivity in depressed 4-to 6-year-old children", J Am Acad Child Adolesc Psychiatry, 52, pp.737~746 (2013)
  31. Stein JL, "Identification of common variants associated with human hippocampal and intracranial volumes", Nat Genet, 44, pp.552~561 (2012)
  32. Lan MJ, "Resting-state amplitude of low-frequency fluctuation is associated with suicidal ideation", Depress Anxiety, 36, pp.433~441 (2019)
  33. Arnone D, "State-dependent changes in hippocampal grey matter in depression", Mol Psychiatry, 18, pp.1265~1272 (2013)
  34. Samann PG, "Prediction of antidepressant treatment response from gray matter volume across diagnostic categories", Eur Neuropsychopharmacol, 23, pp.1503~1515 (2013)
  35. Mannie ZN, "Structural and functional imaging of the hippocampus in young people at familial risk of depression", Psychol Med, 44, pp.2939~2948 (2014)
  36. Maller JJ, "Increased hippocampal tail volume predicts depression status and remission to anti-depressant medications in major depression", Mol Psychiatry, 23, pp.1737~1744 (2018)
  37. Shi XF, "Anterior cingulate cortex choline levels in female adolescents with unipolar versus bipolar depression : a potential new tool for diagnosis", J Affect Disord, 167, pp.25~29 (2014)
  38. Riley CA, "Brain choline in major depression : A review of the literature", Psychiatry Res Neuroimaging, 271, pp.142~153 (2018)
  39. Lai CH, "The regional homogeneity of cingulate-precuneus regions : The putative biomarker for depression and anxiety", J Affect Disord, 229, pp.171~176 (2018)
  40. Lai CH, "Gray matter volume in major depressive disorder : a meta-analysis of voxel-based morphometry studies", Psychiatry Res, 211, pp.37~46 (2013)
  41. Sundermann B, "Toward literature-based feature selection for diagnostic classification : a meta-analysis of resting-state fMRI in depression", Front Hum Neurosci, 8, pp.692~ (2014)
  42. Boehringer A, "Neural Correlates of the Cortisol Awakening Response in Humans", Neuropsychopharmacology, 40, pp.2278~2285 (2015)
  43. Sato JR, "Machine learning algorithm accurately detects fMRI signature of vulnerability to major depression", Psychiatry Res, 233, pp.289~291 (2015)
  44. Lai CH, "The alterations in regional homogeneity of parieto-cingulate and temporo-cerebellum regions of first-episode medication-naive depression patients", Brain Imaging Behav, 10, pp.187~194 (2016)
  45. Argyelan M, "Subgenual cingulate cortical activity predicts the efficacy of electroconvulsive therapy", Transl Psychiatry, 6, pp.e789~ (2016)
  46. Pirnia T, "Electroconvulsive therapy and structural neuroplasticity in neocortical, limbic and paralimbic cortex", Transl Psychiatry, 6, pp.e832~ (2016)
  47. Serra-Blasco M, "Naturalistic course of major depressive disorder predicted by clinical and structural neuroimaging data : a 5-year follow-up", Depress Anxiety, 33, pp.1055~1064 (2016)
  48. Boes AD, "Rostral anterior cingulate cortex is a structural correlate of repetitive TMS treatment response in depression", Brain Stimul, 11, pp.575~581 (2018)
  49. Grieve SM, "Prediction of nonremission to antidepressant therapy using diffusion tensor imaging", J Clin Psychiatry, 77, pp.e436~443 (2016)
  50. Rzepa E, "Blunted neural response to anticipation, effort and consummation of reward and aversion in adolescents with depression symptomatology", J Psychopharmacol, 31, pp.303~311 (2017)
  51. Brakowski J, "Resting state brain network function in major depression-Depression symptomatology, antidepressant treatment effects, future research", J Psychiatr Res, 92, pp.147~159 (2017)
  52. Bijsterbosch JD, "Stratification of MDD and GAD patients by resting state brain connectivity predicts cognitive bias", Neuroimage Clin, 19, pp.425~433 (2018)
  53. Caceda R, "Modes of resting functional brain organization differentiate suicidal thoughts and actions: a preliminary study", J Clin Psychiatry, 79 (2018)
  54. Gao S, "Machine learning in major depression : From classification to treatment outcome prediction", CNS Neurosci Ther, 24, pp.1037~1052 (2018)
  55. Zhang FF, "Brain structure alterations in depression : Psychoradiological evidence", CNS Neurosci Ther, 24, pp.994~1003 (2018)
  56. Lai CH, "Alterations in white matter micro-integrity of the superior longitudinal fasciculus and anterior thalamic radiation of young adult patients with depression", Psychol Med, 44, pp.2825~2832 (2014)
  57. Lai CH, "The white matter microintegrity alterations of neocortical and limbic association fibers in major depressive disorder and panic disorder: the comparison", Medicine (Baltimore), 95, pp.e2982~ (2016)
  58. Lai CH, "The neural markers of MRI to differentiate depression and panic disorder", Prog Neuropsychopharmacol Biol Psychiatry, 91, pp.72~78 (2019)
  59. Sun Y, "Indicators for remission of suicidal ideation following magnetic seizure therapy in patients with treatment-resistant depression", JAMA Psychiatry, 73, pp.337~345 (2016)
  60. Korgaonkar MS, "Using standardized fMRI protocols to identify patterns of prefrontal circuit dysregulation that are common and specific to cognitive and emotional tasks in major depressive disorder : first wave results from the iSPOT-D study", Neuropsychopharmacology, 38, pp.863~871 (2013)
  61. Vlasova RM, "Resilience and white matter integrity in geriatric depression", Am J Geriatr Psychiatry, 26, pp.874~883 (2018)
  62. Li B, "A treatmentresistant default mode subnetwork in major depression", Biol Psychiatry, 74, pp.48~54 (2013)
  63. Wall CA, "Magnetic resonance imaging-guided, open-label, high-frequency repetitive transcranial magnetic stimulation for adolescents with major depressive disorder", J Child Adolesc Psychopharmacol, 26, pp.582~589 (2016)
  64. Oliveira-Maia AJ, "Modulation of motor cortex excitability predicts antidepressant response to prefrontal cortex repetitive transcranial magnetic stimulation", Brain Stimul, 10, pp.787~794 (2017)
  65. Stange JP, "Attenuated intrinsic connectivity within cognitive control network among individuals with remitted depression : Temporal stability and association with negative cognitive styles", Hum Brain Mapp, 38, pp.2939~2954 (2017)
  66. Vink JJT, "A novel concurrent TMS-fMRI method to reveal propagation patterns of prefrontal magnetic brain stimulation", Hum Brain Mapp, 39, pp.4580~4592 (2018)
  67. Abdallah CG, "Prefrontal connectivity and glutamate transmission : relevance to depression pathophysiology and ketamine treatment", Biol Psychiatry Cogn Neurosci Neuroimaging, 2, pp.566~574 (2017)
  68. Ribeiz SR, "Structural brain changes as biomarkers and outcome predictors in patients with late-life depression : a cross-sectional and prospective study", PLoS One, 8, pp.e80049~ (2013)
  69. Dai Q, "Orbito-frontal cortex mechanism of inhibition of return in current and remitted depression", Hum Brain Mapp, 39, pp.2941~2954 (2018)
  70. Bajs Janovic M, "No change in N-acetyl aspartate in first episode of moderate depression after antidepressant treatment : (1)H magnetic spectroscopy study of left amygdala and left dorsolateral prefrontal cortex", Neuropsychiatr Dis Treat, 10, pp.1753~1762 (2014)
  71. Brunoni AR, "BDNF blood levels after non-invasive brain stimulation interventions in major depressive disorder : a systematic review and meta-analysis", World J Biol Psychiatry, 16, pp.114~122 (2015)
  72. Oltedal L, "Volume of the Human Hippocampus and Clinical Response Following Electroconvulsive Therapy", Biol Psychiatry, 84, pp.574~581 (2018)
  73. Zwanzger P, "Impact of electroconvulsive therapy on magnetoencephalographic correlates of dysfunctional emotional processing in major depression", Eur Neuropsychopharmacol, 26, pp.684~692 (2016)
  74. Chattun MR, "Caudothalamic dysfunction in drug-free suicidally depressed patients: an MEG study", Eur Arch Psychiatry Clin Neurosci (2018)
  75. Fernandez A, "Complexity analysis of spontaneous brain activity in mood disorders : A magnetoencephalography study of bipolar disorder and major depression", Compr Psychiatry, 84, pp.112~117 (2018)
  76. Nugent AC, "Multimodal imaging reveals a complex pattern of dysfunction in corticolimbic pathways in major depressive disorder", Hum Brain Mapp, 40, pp.3940~3950 (2019)
  77. Wang Q, "Identification of major depressive disorder and prediction of treatment response using functional connectivity between the prefrontal cortices and subgenual anterior cingulate : A real-world study", J Affect Disord, 252, pp.365~372 (2019)
  78. Tian S, "Dynamic community structure in major depressive disorder : A resting-state MEG study", Prog Neuropsychopharmacol Biol Psychiatry, 92, pp.39~47 (2019)
  79. Nugent AC, "Preliminary differences in resting state MEG functional connectivity pre- and postketamine in major depressive disorder", Psychiatry Res Neuroimaging, 254, pp.56~66 (2016)
  80. Nugent AC, "Group differences in MEG-ICA derived resting state networks: Application to major depressive disorder", Neuroimage, 118, pp.1~12 (2015)
  81. Lu Q, "Impaired prefrontal-amygdala effective connectivity is responsible for the dysfunction of emotion process in major depressive disorder : a dynamic causal modeling study on MEG", Neurosci Lett, 523, pp.125~130 (2012)
  82. Pu S, "Suicidal ideation is associated with reduced prefrontal activation during a verbal fluency task in patients with major depressive disorder", J Affect Disord, 181, pp.9~17 (2015)
  83. Kawano M, "Correlation between frontal lobe oxy-hemoglobin and severity of depression assessed using near-infrared spectroscopy", J Affect Disord, 205, pp.154~158 (2016)
  84. Kinoshita S, "Clinical application of DEX", CRH test and multi-channel NIRS in patients with depression, 2016, pp.12, 25~
  85. Gao L, "Probing prefrontal cortex hemodynamic alterations during facial emotion recognition for major depression disorder through functional near-infrared spectroscopy", J Neural Eng, 16, pp.026026~ (2019)
  86. Yoshitaka Nishizawa, "fNIRS Assessment during an Emotional Stroop Task among Patients with Depression: Replication and Extension", PSYCHIATRY INVESTIGATION, 16(1), pp.80~86 (2019), 대한신경정신의학회[DOI]
  87. Yamagata B, "Brain functional alterations observed 4-weekly in major depressive disorder following antidepressant treatment", J Affect Disord, 252, pp.25~31 (2019)
  88. Satomura Y, "Severity-dependent and-independent brain regions of major depressive disorder : A long-term longitudinal near-infrared spectroscopy study", J Affect Disord, 243, pp.249~254 (2019)
  89. Liu X, "Relationship between the prefrontal function and the severity of the emotional symptoms during a verbal fluency task in patients with major depressive disorder : a multi-channel NIRS study", Prog Neuropsychopharmacol Biol Psychiatry, 54, pp.114~121 (2014)
  90. Matsubara T, "Prefrontal activation in response to emotional words in patients with bipolar disorder and major depressive disorder", Neuroimage, (85 Pt 1), pp.489~497 (2014)
  91. Takei Y, "Near-infrared spectroscopic study of frontopolar activation during face-to-face conversation in major depressive disorder and bipolar disorder", J Psychiatr Res, 57, pp.74~83 (2014)
  92. Akashi H, "Prefrontal cortex activation is associated with a discrepancy between self-and observer-rated depression severities of major depressive disorder : a multichannel near-infrared spectroscopy study", J Affect Disord, 174, pp.165~172 (2015)
  93. Hegerl U, "Why do stimulants not work in typical depression?", Aust N Z J Psychiatry, 51, pp.20~22 (2017)
  94. Olbrich S, "EEG vigilance regulation patterns and their discriminative power to separate patients with major depression from healthy controls", Neuropsychobiology, 65, pp.188~194 (2012)
  95. Bailey NW, "Responders to rTMS for depression show increased frontomidline theta and theta connectivity compared to non-responders", Brain Stimul, 11, pp.190~203 (2018)
  96. Fitzgerald PJ, "Gamma oscillations as a biomarker for major depression : an emerging topic", Transl Psychiatry, 8, pp.177~ (2018)
  97. Pizzagalli DA, "Resting anterior cingulate activity and abnormal responses to errors in subjects with elevated depressive symptoms : a 128-channel EEG study", Hum Brain Mapp, 27, pp.185~201 (2006)
  98. Noda Y, "Resting-state EEG gamma power and theta-gamma coupling enhancement following high-frequency left dorsolateral prefrontal rTMS in patients with depression", Clin Neurophysiol, 128, pp.424~432 (2017)
  99. Korb AS, "Rostral anterior cingulate cortex theta current density and response to antidepressants and placebo in major depression", Clin Neurophysiol, 120, pp.1313~1319 (2009)
  100. Gordon E, "EEG alpha asymmetry in schizophrenia, depression, PTSD, panic disorder, ADHD and conduct disorder", Clin EEG Neurosci, 41, pp.178~183 (2010)
  101. Pillai V, "A meta-analysis of electroencephalographic sleep in depression : evidence for genetic biomarkers", Biol Psychiatry, 70, pp.912~919 (2011)
  102. Adamczyk M, "Cordance derived from REM sleep EEG as a biomarker for treatment response in depression--a naturalistic study after antidepressant medication", J Psychiatr Res, 63, pp.97~104 (2015)
  103. Tesler N, "Increased frontal sleep slow wave activity in adolescents with major depression", Neuroimage Clin, 10, pp.250~256 (2016)
  104. Baskaran A, "The comparative effectiveness of electroencephalographic indices in predicting response to escitalopram therapy in depression : A pilot study", J Affect Disord, 227, pp.542~549 (2018)
  105. Hunter AM, "Change in quantitative EEG theta cordance as a potential predictor of repetitive transcranial magnetic stimulation clinical outcome in major depressive disorder", Clin EEG Neurosci, 49, pp.306~315 (2018)
  106. Frokjaer VG, "Frontolimbic serotonin 2A receptor binding in healthy subjects is associated with personality risk factors for affective disorder", Biol Psychiatry, 63, pp.569~576 (2008)
  107. McGrath CL, "Toward a neuroimaging treatment selection biomarker for major depressive disorder", JAMA Psychiatry, 70, pp.821~829 (2013)
  108. -zient PET imaging, "Depress Anxiety", 2013, 902~907
  109. Kaufman J, "Quantification of the serotonin 1A receptor using PET : identification of a potential biomarker of major depression in males", Neuropsychopharmacology, 40, pp.1692~1699 (2015)
  110. Wu KY, "Diversity of neurodegenerative pathophysiology in nondemented patients with major depressive disorder : Evidence of cerebral amyloidosis and hippocampal atrophy", Brain Behav, 8, pp.e01016~ (2018)
  111. Ananth MR, "Decreased pretreatment amygdalae serotonin transporter binding in unipolar depression remitters : a prospective PET study", J Nucl Med, 59, pp.665~670 (2018)
  112. Richards EM, "PET radioligand binding to translocator protein(TSPO)is increased in unmedicated depressed subjects", EJNMMI Res, 8, pp.57~ (2018)
  113. McGrath CL, "Pretreatment brain states identify likely nonresponse to standard treatments for depression", Biol Psychiatry, 76, pp.527~535 (2014)
  114. Harrison SJ, "Light therapy and serotonin transporter binding in the anterior cingulate and prefrontal cortex", Acta Psychiatr Scand, 132, pp.379~388 (2015)
  115. Sacher J, "Relationship of monoamine oxidase-A distribution volume to postpartum depression and postpartum crying", Neuropsychopharmacology, 40, pp.429~435 (2015)
  116. Conen S, "Acute and chronic changes in brain activity with deep brain stimulation for refractory depression", J Psychopharmacol, 32, pp.430~440 (2018)
  117. Jha S, "Brain SPECT guided repetitive transcranial magnetic stimulation(rTMS)in treatment resistant major depressive disorder", Asian J Psychiatr, 21, pp.1~6 (2016)
  118. Hsieh PC, "Lower availability of midbrain serotonin transporter between healthy subjects with and without a family history of major depressive disorder-a preliminary two-ligand SPECT study", Eur Psychiatry, 29, pp.414~418 (2014)
  119. Ruhe HG, "Occupancy of serotonin transporters in the amygdala by paroxetine in association with attenuation of left amygdala activation by negative faces in major depressive disorder", Psychiatry Res, 221, pp.155~161 (2014)
  120. Newberg AB, "Low brain serotonin transporter binding in major depressive disorder", Psychiatry Res, 202, pp.161~167 (2012)
  121. Nagafusa Y, "Assessment of cerebral blood flow findings using 99mTc-ECD single-photon emission computed tomography in patients diagnosed with major depressive disorder", J Affect Disord, 140, pp.296~299 (2012)
  122. Ruhe HG, "Serotonin transporter gene promoter polymorphisms modify the association between paroxetine serotonin transporter occupancy and clinical response in major depressive disorder", Pharmacogenet Genomics, 19, pp.67~76 (2009)
  123. Ruhe HG, "Evidence why paroxetine dose escalation is not effective in major depressive disorder : a randomized controlled trial with assessment of serotonin transporter occupancy", Neuropsychopharmacology, 34, pp.999~1010 (2009)
  124. beta-CIT SPECT in major depressive disorder versus controls : effect of season and gender, "Eur J Nucl Med Mol Imaging", 2009, 841~849

관련 논문AI추천

이 간행물의 다른 논문 (10건)